At our cutting-edge AI and Physics-based drug discovery platform, we incorporate advanced screening methodologies to our proprietary insilico tools to evaluate millions of potential drug candidates for specific disease related targets. We help in cutting down your R&D time for early stage drug design and screening from 18 months to 6 months by using the power of AI, high performance computing and cloud computing.
Our multi-target multi-ligand screening methodology follows a rigorous three-stage process which encompasses molecular docking, full atomistic molecular dynamics, and meta-dynamics based free energy calculations to execute a proficient binding interaction study. This three step methodology helps in reducing the false positive (from docking only methods) by more than 90% and we provide quantitative predictions. The same methodology is well tested for repurposing as well. If you are looking for synergistic molecules along with an existing drug our AI and physics-based platform is one of the forerunners in this domain.
Our platform utilizes advanced scoring functions for highly accurate quantitative predictions, ensuring the selection of optimal efficacy drug candidates with exceptional specificity to the target of study. Additionally, we offer comprehensive solutions to various challenges in the field of drug development making sure that our service will bring out the best of your study. Apart from that our platform helps you for accurate predictions of physico-chemical properties. These invaluable insights from our platform contribute to well-informed decision-making and expedite the drug discovery process.
With the aid of our groundbreaking drug discovery platform,supported by rigorous scientific methodologies and advanced computational techniques we are revolutionizing the idea of drug discovery by delivering highly specific and effective drug candidates.
Partner with us to explore and unlock novel possibilities in highly efficient discovery and repurposing of drug molecules for a healthier future.